resiquimod has been researched along with Disease Models, Animal in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (6.06) | 29.6817 |
2010's | 24 (72.73) | 24.3611 |
2020's | 7 (21.21) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Hong, WH; Hwang, YS; Lee, MH; Liu, CL; Lo, SM; Shen, CN; Shen, CR; Yang, WC | 1 |
Belt, BA; Garrett-Larsen, J; Gerber, SA; Han, BJ; Johnston, CJ; Linehan, DC; Lord, EM; Mills, BN; Murphy, JD; Qin, SS; Uccello, TP; Vrooman, TG; Ye, J | 1 |
Liu, S; Liu, Z; Mao, H; Qiu, C; Wang, X; Xie, Y; Xiong, Y; Yu, M; Zhu, Z | 1 |
Johansson, C; Makris, S | 1 |
Chen, H; Chen, X; Deng, F; Gong, W; Huang, K; Hui, X; Jin, M; Sun, X; Tao, YJ; Wang, T; Yang, Y; Zhang, Q; Zhang, S; Zhang, Y; Zhao, Y; Zou, Z | 1 |
Ahn, JS; Ahn, MJ; Ha, SJ; Heo, JY; Kim, JE; Kim, MS; Kim, S; Kim, SY; Koh, J; Ku, BM; Lee, KY; Lee, SH; Lee, SN; Lim, YT; Park, K; Park, YM; Sun, JM; Yang, S | 1 |
Bergmann, CC; DiSano, KD; Stohlman, SA | 1 |
Altman, MD; Andresen, B; Baker, J; Brubaker, JD; Chen, H; Chen, Y; Childers, M; Donofrio, A; Ferguson, H; Fischer, C; Fischmann, TO; Gibeau, C; Hicks, A; Jin, S; Kattar, S; Kleinschek, MA; Leccese, E; Lesburg, C; Li, C; Lim, J; Liu, D; Maclean, JKF; Mansoor, F; Moy, LY; Mulrooney, EF; Necheva, AS; Northrup, A; Presland, J; Rakhilina, L; Smith, GF; Torres, L; Yang, R; Zhang-Hoover, J | 1 |
Ascherman, DP; Doglio, MG; Manfredi, AA; Monno, A; Rigamonti, E; Rovere-Querini, P; Sciorati, C | 1 |
Bashir, K; Chellappa, MM; Dey, S; Krishnaswamy, N; Kumar, A; Matoo, JJ; Ramakrishnan, S | 1 |
Chen, B; Fan, H; Li, M; Qin, T; Qu, S; Wei, J; Ye, L; Zhang, S | 1 |
Bahrami, F; Niknam, HM; Rostamian, M | 1 |
Ainslie, KM; Bachelder, EM; Brackman, DJ; Gupta, G; Papenfuss, TL; Peine, KJ; Satoskar, AR | 1 |
Heinz, A; Krause, M; Maxeiner, J; Naito, S; Reuter, S; Scheurer, S; Schülke, S; Siebeneicher, S; Taube, C; Toda, M; Vieths, S; Wangorsch, A; Wolfheimer, S | 1 |
Klier, U; Linnebacher, M; Maletzki, C; Stier, S | 1 |
Fujimoto, C; Kamijima, R; Kataoka, S; Nakajima, K; Sano, S; Takaishi, M; Terada, Y; Yokogawa, M | 1 |
Birnbaum, R; Bruhn, KW; Craft, N; Erfe, MC; Haskell, J; Quanquin, N; Quant, C | 1 |
Chodaczek, G; Cominelli, F; Goodman, W; Johnson, R; Kim, G; Ley, K; Mikulski, Z; Nowyhed, H; Pizarro, TT; Shaked, I | 1 |
Cascalho, M; Clark, KL; Kahlenberg, JM; Morse, MD | 1 |
Ainslie, KM; Bachelder, EM; Bell, MG; Elberson, MA; Gallovic, MD; Gautam, S; Keane-Myers, A; Peine, KJ; Pesce, JT; Prouty, AM; Schully, KL; Sharma, S | 1 |
Alexander-Miller, MA; Aycock, ST; Blevins, LK; D'Agostino, RB; Hadimani, MB; Holbrook, BC; Jorgensen, MJ; Kim, JR; King, SB; Kock, ND; Parks, GD | 1 |
Di, T; Li, P; Lin, Y; Liu, X; Meng, Y; Ruan, Z; Wang, M; Wang, N; Wang, Y; Xie, X; Zhang, L; Zhao, J | 1 |
Cheadle, EJ; Dovedi, SJ; Fagnano, E; Honeychurch, J; Illidge, TM; Klein, C; Lipowska-Bhalla, G | 1 |
Caisová, V; Chmelař, J; Glaserová, S; Husníková, H; Jochmanová, I; Kopecký, J; Krejčová, G; Kumžáková, Z; Paďouková, L; Vácová, N; Vieru, A; Wolf, KI; Ženka, J | 1 |
Baxan, N; Bellahcene, M; Branca, J; Dent, O; Duffy, T; Hameed, TS; Harding, SE; Hasham, MG; Perkins, B; Rosenthal, N; Sattler, S; Schneider, MD; Stella, SE; Stuckey, DJ | 1 |
Ahmad, G; Noor, Z; Siddiqui, AA; Torben, W; Zhang, W | 1 |
Bardel, E; Dy, M; Gregoire, S; Schneider, E; Thieblemont, N; Van, LP; Vanoirbeek, J | 1 |
Becker, M; Böhm, L; Buhl, R; Dehzad, N; Martin, H; Reuter, S; Stassen, M; Taube, C | 1 |
Bogdahn, U; Chirasani, SR; Gottfried, E; Grauer, OM; Gronwald, W; Hau, P; Hochrein, J; Kreutz, M; Leukel, P; Neumann, B; Oefner, PJ; Stadler, K | 1 |
Adlard, AL; Dovedi, SJ; Honeychurch, J; Illidge, TM; Melis, MH; Stratford, IJ; Wilkinson, RW | 1 |
Fredin, MF; Gillberg, PG; Jägervall, K; Jansson, L; Karlsson, A; Karlsson, L; Melgar, S; Michaëlsson, E; Rehnström, E; Utkovic, H | 1 |
Camateros, P; Guiot, MC; Hassan, M; Marino, R; Marion, D; Martin, JG; Moisan, J; Radzioch, D; Tamaoka, M | 1 |
33 other study(ies) available for resiquimod and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Inhibiting TLR7 Expression in the Retinal Pigment Epithelium Suppresses Experimental Autoimmune Uveitis.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Gene Expression Regulation; Imidazoles; Membrane Glycoproteins; Mice; Retinal Pigment Epithelium; Signal Transduction; Toll-Like Receptor 7; Uveitis | 2021 |
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.
Topics: Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Carcinoma, Pancreatic Ductal; CD8-Positive T-Lymphocytes; Disease Models, Animal; Humans; Imidazoles; Liver Neoplasms; Mice; Pancreatic Neoplasms; Radiosurgery; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Microenvironment | 2022 |
TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Communication; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Imidazoles; Macrophages; Male; Membrane Glycoproteins; Mice; Myeloid-Derived Suppressor Cells; Oxaliplatin; RAW 264.7 Cells; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Microenvironment | 2020 |
R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice.
Topics: Adaptor Proteins, Vesicular Transport; Age Factors; Animals; Animals, Newborn; Cyclic AMP; Cytokines; Disease Models, Animal; Host-Pathogen Interactions; Imidazoles; Immunity, Innate; Lung; Macrophages, Alveolar; Mice; Myeloid Differentiation Factor 88; Orthomyxoviridae; Orthomyxoviridae Infections; Respiratory Syncytial Virus Infections; Signal Transduction | 2021 |
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
Topics: Adaptation, Physiological; Amino Acid Substitution; Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Caco-2 Cells; Chlorocebus aethiops; COVID-19; Disease Models, Animal; Female; High-Throughput Nucleotide Sequencing; Humans; Imidazoles; Mice; Mice, Inbred BALB C; SARS-CoV-2; Serial Passage; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication; Whole Genome Sequencing | 2021 |
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Emulsions; Humans; Imidazoles; Immune Checkpoint Inhibitors; Lung Neoplasms; Lymphocyte Activation; Mice; Programmed Cell Death 1 Receptor; Toll-Like Receptor 7; Toll-Like Receptor 8; Tumor Microenvironment | 2021 |
An optimized method for enumerating CNS derived memory B cells during viral-induced inflammation.
Topics: Animals; Antibody-Producing Cells; B-Lymphocytes; Cell Differentiation; Cell Movement; Central Nervous System; Cyclopropanes; Cytokines; Disease Models, Animal; Flow Cytometry; Guanosine; Hepatitis, Viral, Animal; Imidazoles; In Vitro Techniques; Inflammation; Mice; Mice, Inbred C57BL; Murine hepatitis virus; Spinal Cord; Spleen; Time Factors; Toll-Like Receptor 1 | 2017 |
Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; High-Throughput Screening Assays; Imidazoles; Inflammation; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Inbred Lew; Structure-Activity Relationship | 2017 |
Exacerbation of Murine Experimental Autoimmune Myositis by Toll-Like Receptor 7/8.
Topics: Animals; Autoantibodies; Disease Models, Animal; Disease Progression; Histidine-tRNA Ligase; Imidazoles; Major Histocompatibility Complex; Mice; Muscle, Skeletal; Myositis; Nervous System Autoimmune Disease, Experimental; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2018 |
Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chickens; Coronavirus Infections; Disease Models, Animal; Imidazoles; Immunity; Immunity, Cellular; Immunity, Humoral; Immunity, Mucosal; Immunization; Immunoglobulin A; Infectious bronchitis virus; Leukocytes, Mononuclear; Poultry Diseases; Specific Pathogen-Free Organisms; Transforming Growth Factor beta; Vaccination; Vaccines, Attenuated; Vaccines, Inactivated; Viral Vaccines | 2018 |
The effects of resiquimod in an ovalbumin-induced allergic rhinitis model.
Topics: Animals; Anti-Allergic Agents; Antigens; Cytokines; Disease Models, Animal; Female; Hepatitis A Virus Cellular Receptor 1; Hepatitis A Virus Cellular Receptor 2; Imidazoles; Mice, Inbred BALB C; Nasal Mucosa; Ovalbumin; Rhinitis, Allergic; Spleen | 2018 |
Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; Cytokines; Disease Models, Animal; Female; Imidazoles; Leishmania tropica; Leishmaniasis; Leishmaniasis Vaccines; Lipid A; Mice, Inbred BALB C; Parasite Load; Protozoan Proteins; Random Allocation; Recombinant Proteins; Toll-Like Receptors; Vaccination; Vaccines, Inactivated | 2018 |
Liposomal resiquimod for the treatment of Leishmania donovani infection.
Topics: Administration, Intravenous; Animals; Antiprotozoal Agents; Bone Marrow; Disease Models, Animal; Imidazoles; Interferon-gamma; Interleukin-10; Leishmania donovani; Leishmaniasis, Visceral; Leukocytes, Mononuclear; Liposomes; Liver; Mice; Mice, Inbred BALB C; Parasite Load; Spleen; Treatment Outcome | 2014 |
Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model.
Topics: Administration, Cutaneous; Animals; Antigens, Plant; Asthma; Desensitization, Immunologic; Disease Models, Animal; Female; Imidazoles; Immunization; Immunoglobulin E; Immunoglobulin G; Mice; Premedication; Recombinant Proteins; Th1 Cells | 2014 |
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Imidazoles; Immunomodulation; Immunotherapy; Ligands; Lymphocytes; Mice; Neoplasms; Paclitaxel; Poly I-C; Toll-Like Receptors; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Imidazoles; Imiquimod; Lupus Erythematosus, Systemic; Mice; Skin; Spleen; Toll-Like Receptor 7 | 2014 |
Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemoprevention; Disease Models, Animal; Female; Granulocytes; Imidazoles; Leishmaniasis, Visceral; Liver; Mice, Inbred BALB C; Spleen | 2014 |
SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration.
Topics: Animals; Cell Movement; Chemokine CCL21; Crohn Disease; Dendritic Cells; Disease Models, Animal; Ileitis; Imidazoles; Lymph Nodes; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes, Regulatory; Toll-Like Receptor 7 | 2015 |
Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; B-Lymphocytes; Caspase 1; Cells, Cultured; Disease Models, Animal; Ficoll; Genetic Predisposition to Disease; Imidazoles; Immunization; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Knockout; Nitrophenols; Ovalbumin; Phenotype; Phenylacetates; Spleen; T-Lymphocytes; Terpenes; Time Factors | 2016 |
Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.
Topics: Animals; Bacterial Vaccines; Biodegradable Plastics; Burkholderia pseudomallei; Dextrans; Disease Models, Animal; Drug Carriers; Imidazoles; Melioidosis; Mice; Polymers; Vaccination; Vaccines, Subunit | 2015 |
A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.
Topics: Animals; Animals, Newborn; Antibodies, Viral; Chlorocebus aethiops; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Flagellin; Imidazoles; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Orthomyxoviridae Infections; Toll-Like Receptor 7; Toll-Like Receptor 8; Vaccines, Inactivated | 2016 |
Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway.
Topics: Animals; Cell Differentiation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Humans; Imidazoles; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Interleukin-23; Lithospermum; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; Naphthoquinones; Psoriasis; Skin; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2016 |
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Disease Models, Animal; Humans; Imidazoles; Killer Cells, Natural; Lymphocyte Activation; Lymphoma; Mice; Mice, Inbred C57BL; Rituximab; Toll-Like Receptor 7 | 2017 |
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Imidazoles; Immunity, Innate; Immunotherapy; Ligands; Mannans; Melanoma, Experimental; Mice; Neoplasms; Neutrophil Infiltration; Neutrophils; Phagocytosis; Poly I-C; Respiratory Burst; Toll-Like Receptors | 2016 |
Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease.
Topics: Adaptive Immunity; Adoptive Transfer; Animals; Autoantibodies; Autoimmunity; Cardiomyopathy, Dilated; Disease Models, Animal; Female; Genetic Variation; Heart Function Tests; Imidazoles; Immunity, Cellular; Inflammation; Lymph Nodes; Male; Mutation; Myocarditis; Myocardium; Spleen; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2017 |
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Helminth; Antigens, Helminth; Calpain; Disease Models, Animal; Female; Humans; Imidazoles; Immunization; Mice; Mice, Inbred C57BL; Parasite Egg Count; Schistosoma mansoni; Schistosomiasis mansoni; Treatment Outcome; Vaccines, DNA | 2010 |
Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms.
Topics: Animals; Asthma; Disease Models, Animal; Imidazoles; Interleukin-10; Lung; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Ovalbumin; T-Lymphocytes, Regulatory; Toll-Like Receptor 7; Transforming Growth Factor beta | 2011 |
TLR3 but not TLR7/8 ligand induces allergic sensitization to inhaled allergen.
Topics: Administration, Inhalation; Allergens; Animals; Dendritic Cells; Disease Models, Animal; Hypersensitivity; Imidazoles; Ligands; Lipopolysaccharides; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Ovalbumin; Poly I-C; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2012 |
Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dendritic Cells; Diclofenac; Disease Models, Animal; Female; Glioma; Imidazoles; Immune Tolerance; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-2 Receptor alpha Subunit; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phosphorylation; T-Lymphocytes, Regulatory; Transcriptional Activation; Up-Regulation | 2013 |
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Disease Models, Animal; Imidazoles; Lymphocyte Activation; Lymphoma; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 7 | 2013 |
Intra-colonic administration of the TLR7 agonist R-848 induces an acute local and systemic inflammation in mice.
Topics: Animals; Colon; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Imidazoles; Immunity, Innate; Immunologic Factors; Inflammation; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Toll-Like Receptor 7 | 2008 |
Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463.
Topics: Aminoquinolines; Animals; Cell Proliferation; Chronic Disease; Disease Models, Animal; Goblet Cells; Hyperplasia; Ligands; Lung; Lymphocyte Count; Male; Muscle, Smooth; Rats; Rats, Inbred BN; Th1 Cells; Th2 Cells; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2007 |